Moselle Woman Stopped Anti-Obesity Injections Over Monthly Cost of 340 Euros
A Moselle woman stopped injectable anti-obesity treatment over its roughly 340-euro monthly cost after losing 30 kg.
Event / Health
France Obesity Drug Access
A 44-year-old woman from Moselle describes losing 30 kg over one year on the injectable drugs Wegovy and then Mounjaro, stopping treatment because of an out-of-pocket cost of about 340 euros per month, and regaining two kilograms. The account also describes French prescribing and reimbursement conditions for these injectable medications.
2 reported locations
Daily activity
1 articles0 articles
2026-10-23 to 2026-10-25 · UTC publication dates
Coverage begins 23 Oct, 16:54 UTC
Follow the documented timeline or explore the related reporting.
What happened
Woman regained two kilograms after stopping anti-obesity treatment
After stopping her anti-obesity injection treatment, the woman from Moselle, France, regained two kilograms.
Woman chose her general practitioner over a specialized obesity center
The woman from Moselle, France, chose to obtain her anti-obesity prescription from her general practitioner instead of a specialized obesity center. She cited the distance of the centers from her home and waiting times, and was uncertain she would obtain a place there.
Woman lost five kilograms in the first month of Wegovy treatment
During the first month of Wegovy treatment, the woman from Moselle, France, lost five kilograms.
Doctors in France are authorized to prescribe anti-obesity treatments
In France, general practitioners are authorized to prescribe injectable anti-obesity treatments.
Woman switched from Wegovy to Mounjaro after six months when her weight plateaued
After six months of Wegovy treatment, the weight of the woman from Moselle, France, began to plateau, and she switched to Mounjaro, another injectable anti-obesity drug. Her weight continued to decline.
Woman began Wegovy treatment after her body mass index reached 40
A 44-year-old woman from Moselle, France, began injections of Wegovy after her body mass index reached 40, which met the criteria for morbid or massive obesity. Her treatment included monthly follow-up and blood tests.
Woman plans to maintain her weight through coaching, exercise and nutritionist guidance
After stopping injection treatment, the woman from Moselle, France, planned to maintain her current weight by resuming regular exercise with a coach and following a nutrition plan prepared by a nutritionist.
Woman's cholesterol stabilized during Wegovy treatment after she had been close to diabetes
During Wegovy treatment, the cholesterol of the woman from Moselle, France, stabilized. Before treatment she had been close to developing diabetes.
Woman experienced digestive discomfort, fatigue and minor malaises at the start of Wegovy treatment
At the start of Wegovy treatment, the woman from Moselle, France, experienced intestinal and digestive discomfort, fatigue, and minor malaises. She had been eating very little and could not tolerate fatty foods.
Reimbursement for anti-obesity drugs in France requires care through specialized obesity centers or protocols
In France, reimbursement for injectable anti-obesity treatments requires that prescribing be done by physicians working in specialized obesity centers or under a specialized obesity care protocol.
Woman stopped anti-obesity treatment because of its cost of about 340 euros per month
A 44-year-old woman from Moselle, France, stopped her anti-obesity injection treatment because of cost. The monthly cost was about 340 euros for the injections, plus the cost of medical follow-up.
Injectable anti-obesity medications in France require a medical prescription and supervised care
In France, injectable medications for treating obesity are subject to medical prescription and must be part of an appropriate medical care plan.
Woman says she fears regaining weight and does not intend to use injections for life
The woman from Moselle, France, stated that she fears regaining weight after stopping injection treatment. She stated that at 44 she does not intend to take injections for life.
Woman in Moselle, France, lost 30 kg over one year on injectable anti-obesity drugs
A 44-year-old woman from Moselle, France, lost 30 kg over one year of treatment with the injectable anti-obesity drugs Wegovy and then Mounjaro. Before treatment her body mass index was 40 and her weight had reached 120 kg.
Read the coverage
2 alternative perspectives